References
- CHIOU GCY, CHANG MS: Ocular inflammation induced by lens protein and its prevention with new agents. In: New Trends in Lipid Mediator Research, Lipid Mediators in Eye Inflammation, Bazan NG (Ed.) Karger, Basel (1990) pp 94–109.
- MASUDA K: Anti-inflammatory agents: non-steroidal anti-inflammatory drugs. In: Pharmacology of the Eye, Sears ML (Ed.) Springer-Verlag, New York (1984) pp 539–551.
- BRAQUET P: Handbook of PAF and PAT Antagonists, CRC Press, Boca Raton, FL (1991).
- MEW M, PARENTE L: Cytokines and Lipocortins in Inflam-mation and Differentiation, Wiley-Liss, New York (1990).
- DAWSON MM: Lymphokines and Interleukins, CRC Press, Boca Raton, FL (1991).
- CHIOU GCY, LIU SXL, LI BHP, VARMA RS, CHIANG CH: Ocular hypotensive effects of arginine compounds and their actions on ocular blood flow. J. Ocul. Pharrnacol. Therapeut. (1995) 11:1–10.
- CHIOU GCY, LIU SXL: Novel non-arachidonate mediated, non-steroidal anti-inflammatory agents. Exp. Opin, In-vest. Drugs (1994) 3:725–732.
- CHIOU GCY, YAO QS, LI BHP: Inhibition of lens protein, endotoxin, and IL-I-induced ocular inflammation with osthole and some other non-steroidal anti-inflamma-tory agents. Inflammopharmacol. (1993) 2:5–13.
- CHIOU GCY, YAO QS, VARMA RJ: Inhibition of ocular inflammation by chalcone derivatives and pred-nisolone. J. Ocular Pharmacol. (1992) 8:213–223.
- YAO QS, VARMA RS, LIU SXL, CHIOU GCY: Prevention oflens protein-, endotoxin-, and interleukin- I-induced uveitis with chalcone derivatives. Inflammopharmacol. (1994) 2:401–409.
- MAO JG, CHIOU GCY: Effects of tetrandrine on ocular inflammation induced by 11.-1 and endotoxin. j OcuL Pbarmacol. 7berapeut. (1996) in press.
- CHIOU GCY, YAO QS, CHANG MS, OKAWARA T: Treat-ment of ocular inflammation with a new class of non-steroidal anti-inflammatory agents/ Ocular Pharmacol. (1994) 10:335–347.
- CHIOU GCY, YAO QS, OKAWARA T. Prevention of ocularinflammation induced by lens protein, endotoxin and interleukin-1 with synthetic IL-1 blockers. J. Ocular Pbarmacol. (1994) 10:577–586.
- KING VF, GARCIA ML, HIMMEL D, REUBEN J, TONG LAM YK, PAN JX, HAN GR, KACZOROWSKI GJ: Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin. J. Biol Chem. (1988) 263:2238–2244.
- FANG DC, JIANG MX: A new calcium antagonist of Chinese medicinal origin: tetrandrine. j Hypotension (1986) 4 (Suppl. 6):S150–S152.
- LI OL: The therapeutic effect of tetrandrine on silicosis. Chinese J. Tuberc. Respir. Dis (1981) 4:321–323.
- MAO JG, WANG YL, WU SY, LI JG, ZHANG SP: Inhibitory effect of tetrandrine on lens protein-induced ocular Inflammation in rabbits. J. Ocular Pbarmacol. (1992) 8:309–315.
- XIAO JG, WU SY, WANG YL, LI JG, ZHANG SP: Inhibitoryeffects of tetrandrine on bovine serum albumin-in-duced welds in rabbits. J. Ocular Pbarmacol. (1993) 9:151–156.
- THE BS, SEOW WK, LI SY, THONG YH: Inhibition of prostaglandin and leukotriene generated by the plant alkaloids tetrandrine and berbamine. Int. J lmmuno-pharmacol. (1990) 12:321–326.